文献速递脑血管病

隐源性缺血患者与非隐源性患者的装置检出房颤:ANTARCTICA汇总分析

Device-Detected Atrial Fibrillation in Patients With and Without Cryptogenic Ischemia: The ANTARCTICA Pooled Analysis.
PubMed 文献 · Stroke · 2025-08-06

该研究为个体参与者数据荟萃分析,纳入2项随机对照试验和12项前瞻性研究,共1562例隐源性卒中/TIA患者和474例非隐源性患者。在校正混杂因素后,隐源性卒中/TIA患者房颤检出率更高(调整OR 1.90,95%CI 1.18-3.06,P=0.009),且检出时间更短(中位65天 vs 169天,P<0.001)。

要点

  • 隐源性卒中/TIA患者植入式心电监测检出房颤的风险是非隐源性患者的1.90倍。
  • 隐源性卒中/TIA患者房颤检出时间更短,中位65天。
  • 约47%的隐源性卒中/TIA患者检出的房颤可能为致病性。

核心结论

  • 隐源性卒中/TIA患者植入式心电监测检出房颤率高于非隐源性卒中/非卒中患者,且检出时间更短,部分检出的房颤可能为致病性。

研究设计与样本

  • 个体参与者数据荟萃分析,纳入2项随机对照试验和12项前瞻性研究,共1562例隐源性卒中/TIA患者和474例非隐源性患者。

主要发现

  • 调整后多水平逻辑回归显示,隐源性卒中/TIA患者房颤检出率更高(调整OR 1.90,95%CI 1.18-3.06,P=0.009)。
  • 当对照限制为缺血性卒中或卒中史时,结果相似(调整OR 2.83,95%CI 1.47-5.44,P=0.002)。
  • 隐源性卒中/TIA患者房颤检出时间显著更短(中位65天 vs 169天,P<0.001)。
  • 贝叶斯定理归因风险显示,隐源性卒中/TIA检出的房颤中47%为致病性。

临床怎么用

  • 对隐源性卒中/TIA患者应考虑使用植入式心电监测以早期发现房颤。
  • 检出房颤后需结合归因风险判断其致病可能性,指导抗凝决策。

局限性

  • 研究纳入的研究间患者特征存在差异,可能影响结果解释。
  • 部分变量存在缺失数据,采用多重插补处理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Insertable cardiac monitoring (ICM) detects atrial fibrillation (AF) in substantial proportions of cryptogenic stroke, noncryptogenic ischemic stroke without known AF, and nonstroke patients who are at risk of underlying AF. Given differences in patient characteristics across studies, there may be differences in AF detection rates on ICM across these subgroups that have not been identified. We investigate whether AF detection rates on ICM are higher in cryptogenic stroke or transient ischemic attack (C-IS/TIA) patients compared with individuals with noncryptogenic stroke or without stroke, when accounting for differences in study populations. METHODS: This is an individual-participant data meta-analysis of prospective studies and randomized controlled trials of ICM in C-IS/TIA, noncryptogenic ischemic stroke, and nonstroke patients. Multilevel multivariable logistic regression models were used to test whether C-IS/TIA is associated with increased AF detection relative to other categories. We performed multiple imputation to derive values for variables with <20% missing data and used Rubin's rules to estimate adjusted odds ratios by combining 100 postimputation data sets. The primary outcome was detection of AF. The attributable risk was derived by application of Bayes' Theorem. RESULTS: Two randomized controlled trials and 12 prospective studies were included with a total of 1562 C-IS/TIA patients and 474 non-C-IS/TIA patients. In adjusted multilevel logistic regression analyses, AF detection was higher in C-IS/TIA patients (adjusted odds ratio, 1.90 [95% CI, 1.18-3.06]; P=0.009), indicating that 47% of AF detected in C-IS/TIA is pathogenic. Limiting the comparator group to ischemic stroke or history of stroke yielded similar results (adjusted odds ratio, 2.83 [95% CI, 1.47-5.44]; P=0.002). Days to AF detection were significantly shorter in C-IS/TIA patients (median 65 versus 169; P<0.001). CONCLUSIONS: In this individual-participant data meta-analysis of patients undergoing ICM, AF detection was higher in C-IS/TIA patients, with shorter time to AF detection compared with noncryptogenic/nonstroke individuals. These findings suggest that some of the AF detected in patients with C-IS/TIA may be pathogenic.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Yaghi S, Sposato LA, Shu L, et al. Device-Detected Atrial Fibrillation in Patients With and Without Cryptogenic Ischemia: The ANTARCTICA Pooled Analysis. Stroke. 2025. PMID: 40765508. doi:10.1161/STROKEAHA.125.051749

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。